On 2024-02-22, Harmony Biosciences Holdings, Inc. (HRMY) announced earnings per share of $0.45 for the fiscal quarter ending 2023-12-31, missing the average analyst estimate of $0.74.
The next expected annoucement date for quarterly earnings is 2024-04-30, with an average estimated earnings per share of $0.64 for the fiscal quarter ending 2024-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
---|---|---|---|
2024-02-22 | 2023-12-31 | $0.74 | $0.45 |
2023-10-31 | 2023-09-30 | $0.67 | $0.63 |
2023-08-01 | 2023-06-30 | $0.62 | $0.56 |
2023-05-02 | 2023-03-31 | $0.44 | $0.48 |
2023-02-21 | 2022-12-31 | $0.54 | $1.01 |
2022-11-01 | 2022-09-30 | $0.10 | $0.95 |
2022-08-02 | 2022-06-30 | $0.40 | $0.57 |
2022-05-03 | 2022-03-31 | $0.25 | $0.51 |
2022-02-28 | 2021-12-31 | $0.32 | $0.63 |
2021-11-09 | 2021-09-30 | $0.19 | $0.43 |
2021-08-10 | 2021-06-30 | $0.19 | $0.54 |
2021-05-11 | 2021-03-31 | $-0.02 | $0.38 |
2021-03-25 | 2020-12-31 | $0.11 | $0.25 |
2020-11-12 | 2020-09-30 | $0.00 | $-0.14 |